April 19, 2017 12:07 PM Pacific Daylight Time MADISON, Wis.–(BUSINESS WIRE)–Cellular Dynamics International (CDI), a FUJIFILM company and a leading developer and manufacturer of induced pluripotent stem cells (iPS), today announced it has signed a collaboration agreement with the Harvard Stem Cell Institute (HSCI), a novel network of stem cell scientists that extends from the... Read more
Award Supports International Collaboration on Two-Dimensional Liquid Chromatography SANTA CLARA, Calif., April 19, 2017 Agilent Technologies Inc. (NYSE: A) announced today that Prof. Dwight Stoll has received an Agilent Thought Leader Award in support of his research applying two-dimensional liquid chromatography (2D-LC) to biopharmaceutical analysis. An influential researcher in chromatography, Prof. Stoll specializes in multi-dimensional... Read more
Basel, 19 April 2017 Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS™ (ocrelizumab) in two types of multiple sclerosis Data presentations will include platform sessions and posters across relapsing multiple sclerosis and primary progressive multiple sclerosis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that new data on... Read more
Basel, 18 April 2017 FDA grants Roche’s TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced bladder cancer First and only cancer immunotherapy approved in advanced bladder cancer as initial treatment for those unable to receive cisplatin chemotherapy Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug... Read more
Basel, 18 April 2017 FDA approves Roche’s Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States First and only medicine approved to treat all forms of diabetic retinopathy Granted Priority Review Designation by the FDA based on analysis of results from a National Institutes of... Read more
Basel, 18 April 2017 FDA approves Roche’s Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among working age adults in the United States First and only medicine approved to treat all forms of diabetic retinopathy Granted Priority Review Designation by the FDA based on analysis of results from a National Institutes of... Read more
Download PDF Read more
April 11, 2017 Cooperative Research and Development Agreement (CRADA) to advance and qualify ‘Human Emulation System’ to meet regulatory evaluation criteria for product testing BOSTON, Mass., April 11, 2017 — Emulate, Inc. announced today that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration’s (FDA) Office... Read more
Contaminant analysis has become increasingly important for manufacturing and quality control departments in a wide variety of industries, such as foods, electrical/electronics, and raw materials. In the field of contaminant analysis, EDX spectrometers are mainly used to analyze metals, due to their performance for analyzing inorganic elements. Shimadzu EDX spectrometers are used in a wide... Read more